Tenaya TherapeuticsTNYA +6.30%32 Market Cap is $199.64 Mil as of Jul. 08, 2026. GuruFocus rates TNYA with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 1,421 Biotechnology companies, Tenaya Therapeutics ranks better than 56.23% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tenaya Therapeutics's share price for the quarter that ended in Mar. 2026 was $0.6924. Tenaya Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 217.00 Mil. Therefore, Tenaya Therapeutics's market cap for the quarter that ended in Mar. 2026 was $150.25 Mil.
Tenaya Therapeutics's quarterly market cap
declined
from Sep. 2025 ($265.27 Mil) to Dec. 2025 ($154.22 Mil) and
declined
from Dec. 2025 ($154.22 Mil) to Mar. 2026 ($150.25 Mil).
Tenaya Therapeutics's annual market cap
declined
from Dec. 2023 ($221.39 Mil) to Dec. 2024 ($123.76 Mil) but then
increased
from Dec. 2024 ($123.76 Mil) to Dec. 2025 ($154.22 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tenaya Therapeutics's Enterprise Value for Today is $128.87 Mil.
Tenaya Therapeutics (NAS:TNYA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tenaya Therapeutics Market Cap Related Terms
Tenaya Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for Tenaya Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Tenaya Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenaya Therapeutics Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tenaya Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Tenaya Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Tenaya Therapeutics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenaya Therapeutics (TNYA) has a Market Cap of $199.64 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tenaya Therapeutics and its competitors. According to the industry distribution chart, Tenaya Therapeutics ranks #622 out of 1421 companies in the Biotechnology industry, placing it in the top 43.8%.
Is Tenaya Therapeutics' Market Cap too high?
Tenaya Therapeutics' current Market Cap is $199.64 Mil. The Biotechnology industry median Market Cap is 121.57. Tenaya Therapeutics' value of $199.64 Mil is 64.2% above this industry median. Based on the distribution chart, Tenaya Therapeutics ranks #622 out of 1421 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Tenaya Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Tenaya Therapeutics' Market Cap compare to MIST and NRXP?
According to the Biotechnology industry distribution chart, Tenaya Therapeutics ranks #622 out of 1421 companies for Market Cap. This puts Tenaya Therapeutics in the upper half of its industry. The industry median Market Cap is 121.57. Tenaya Therapeutics' value of $199.64 Mil is 64.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.57, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tenaya Therapeutics's current Market Cap of $199.64 Mil is 64.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tenaya Therapeutics and its competitors. For the Biotechnology industry, the median Market Cap is 121.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenaya Therapeutics's current Market Cap is $199.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenaya Therapeutics stock overvalued right now?
Tenaya Therapeutics (TNYA) has a current Market Cap of $199.64 Mil. The current Market Cap is $199.64 Mil and 64.2% above the Biotechnology industry median of 121.57. Tenaya Therapeutics' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Tenaya Therapeutics (TNYA), the current Market Cap is $199.64 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
32GF Score
Get the complete analysis for TNYA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TNYA has been successfully added to your 
